Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bruchfeld

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
The European Respiratory Journal|August 29, 2020
Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascadeJoanna Nederby Öhd, Maria-Pia Hergens, Yauheni Luksha, et al.
British Journal of Clinical Pharmacology|January 19, 2021
Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort studyYazhou Gao, Lina Davies Forsman, Weihua Ren, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TBKatarina Niward, Kristian Ängeby, Erja Chryssanthou, et al.
Infectious Diseases of Poverty|July 20, 2020
Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort studyXu-Bin Zheng, Vinod K Diwan, Qi Zhao, et al.
Journal of Rehabilitation Medicine|October 23, 2025
Physical activity, sedentary time, and associated factors in post-COVID-19 condition: a cross-sectional studyAnna Törnberg, Anna Svensson-Raskh, Lucian Bezuidenhout, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosisRobin J Svensson, Katarina Niward, Lina Davies Forsman, et al.
Plos One|November 13, 2012
Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising markerEmilie Borgström, Peter Andersen, Fredrik Atterfelt, et al.
Scientific Reports|March 14, 2023
Stress native T1 and native T2 mapping compared to myocardial perfusion reserve in long-term follow-up of severe Covid-19Jannike Nickander, Rebecka Steffen Johansson, Klara Lodin, et al.
Plos One|December 2, 2025
Pulmonary vascular and airway changes in previously hospitalised COVID-19 patients: Long-term functional respiratory imaging findings correlate with reduced DLCOAnn Mari Svensson, Mikael Björnson, Magnus Sköld, et al.
ERJ Open Research|February 19, 2019
Biomarkers for tuberculosis: the case for lipoarabinomannanMargarida Correia-Neves, Gabrielle Fröberg, Liudmyla Korshun, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
The European Respiratory Journal|August 29, 2020
Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascadeJoanna Nederby Öhd, Maria-Pia Hergens, Yauheni Luksha, et al.
British Journal of Clinical Pharmacology|January 19, 2021
Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort studyYazhou Gao, Lina Davies Forsman, Weihua Ren, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TBKatarina Niward, Kristian Ängeby, Erja Chryssanthou, et al.
Infectious Diseases of Poverty|July 20, 2020
Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort studyXu-Bin Zheng, Vinod K Diwan, Qi Zhao, et al.
Journal of Rehabilitation Medicine|October 23, 2025
Physical activity, sedentary time, and associated factors in post-COVID-19 condition: a cross-sectional studyAnna Törnberg, Anna Svensson-Raskh, Lucian Bezuidenhout, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosisRobin J Svensson, Katarina Niward, Lina Davies Forsman, et al.
Plos One|November 13, 2012
Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising markerEmilie Borgström, Peter Andersen, Fredrik Atterfelt, et al.
Scientific Reports|March 14, 2023
Stress native T1 and native T2 mapping compared to myocardial perfusion reserve in long-term follow-up of severe Covid-19Jannike Nickander, Rebecka Steffen Johansson, Klara Lodin, et al.
Plos One|December 2, 2025
Pulmonary vascular and airway changes in previously hospitalised COVID-19 patients: Long-term functional respiratory imaging findings correlate with reduced DLCOAnn Mari Svensson, Mikael Björnson, Magnus Sköld, et al.
ERJ Open Research|February 19, 2019
Biomarkers for tuberculosis: the case for lipoarabinomannanMargarida Correia-Neves, Gabrielle Fröberg, Liudmyla Korshun, et al.
Pageof 10